These findings suggest that ZMAT3 could serve as a valuable target for therapeutic interventions aimed at mitigating age- and obesity-related muscle dysfunction, particularly by restoring muscle regeneration and insulin sensitivity. The gene discussed is ZMAT3; the disease is obesity disorder.